Product Theater
at Partners In Treatment: SCottsdale

Join Johnson & Johnson for an Exclusive Product Theater at the 2026 Partners In Treatment Conference!
Psychiatrists, Psychiatric Nurse Practitioners (PNPs), and Physician Assistants (PAs) — elevate your practice and join us for a complimentary Product Theater hosted by Johnson & Johnson at the 2026 Partners In Treatment (PIT) Conference in Scottsdale, Arizona.
“When Antidepressants Aren’t Enough: Understanding Unmet Needs as Drivers of Treatment Strategy”
This session highlights what is at stake when unresolved symptoms persist in patients with major depressive disorder despite antidepressant treatment. We will follow a clinical scenario involving a patient with persistent symptoms and review the evidence supporting adjunctive atypical antipsychotic therapy. Key clinical trial data relevant to adjunctive treatment decisions in psychiatry will be discussed.
The consultant is a paid speaker for Johnson & Johnson. The speaker is presenting on behalf of Johnson & Johnson and must present information in compliance with FDA requirements applicable to Johnson & Johnson. CME credits are not available.
Event Details
- Date & Time: Thursday, April 23, 2026 from 12:00 PM – 1:00 PM
- Location: Ember Restaurant at We-Ko-Pa Resort – Savor a delicious gourmet lunch in this stunning desert-view venue, featuring wood-fired specialties and a relaxed atmosphere perfect for meaningful discussions!
- Availability: Spots are available on a first-come, first-served basis. Seating is extremely limited. Once sold out, we will open up a waiting list.
Why Attend?
- Hear directly from a renowned behavioral health expert on the latest data transforming care for serious mental illnesses.
- Connect with fellow behavioral health prescribers in an engaging, low-pressure setting.
- FREE Perks: Your ticket and gourmet lunch are completely free! Plus, receive a complimentary Clinical Attendee Pass to the full Partners In Treatment Conference on Mental Health (April 22–24), unlocking valuable CEUs and sessions focused on integrated mental health care.

Speaker:Robert McCarron, DO
This exclusive session is designed specifically for psychiatrists, PNPs, and PAs committed to advancing patient outcomes in behavioral health. Space is limited — don’t miss this opportunity to stay at the forefront of neuropsychiatry innovation!
Complete the quick form below to secure your spot. Seating is very limited and will be assigned on a first-come, first-served basis! We’ll confirm your attendance and provide full event details promptly.
Open to all licensed psychiatrists, psychiatric nurse practitioners, and physician assistants. No cost to attend. You will be emailed a code to redeem your free Clinical Attendee Pass at the Partners In Treatment Conference on Mental Health: Scottsdale. You must attend the Product Theater for your Clinical Attendee Pass to be valid.
Register for FREE Below
"*" indicates required fields

Johnson & Johnson is a global healthcare leader, committed to solving the toughest health challenges and transforming lives through research, development, manufacture and distribution of innovative medicines and medical technologies. The company’s Innovative Medicine business advances breakthrough science and develops transformational treatments in areas like oncology, immunology, neuroscience, and cardiopulmonary. In MedTech, the company is focused on developing and delivering cardiovascular, orthopaedics, surgery, and vision solutions. Visit jnj.com to learn more.